Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 17;27(2):298-301.
doi: 10.1021/acs.bioconjchem.5b00504. Epub 2015 Oct 28.

(18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry

Affiliations

(18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry

Jan-Philip Meyer et al. Bioconjug Chem. .

Abstract

A first-of-its-kind (18)F pretargeted PET imaging approach based on the bioorthogonal inverse electron demand Diels-Alder (IEDDA) reaction between tetrazine (Tz) and trans-cyclooctene (TCO) is presented. As proof-of-principle, a TCO-bearing immunoconjugate of the anti-CA19.9 antibody 5B1 and an Al[(18)F]NOTA-labeled tetrazine radioligand were harnessed for the visualization of CA19.9-expressing BxPC3 pancreatic cancer xenografts. Biodistribution and (18)F-PET imaging data clearly demonstrate that this methodology effectively delineates tumor mass with activity concentrations up to 6.4 %ID/g at 4 h after injection of the radioligand.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following competing financial interest(s): Wolfgang W. Scholz is an employee of MabVax Therapeutics and has an equity interest.

Figures

Scheme 1
Scheme 1. Radiochemical Synthesis of the Radioligand Tz-PEG11-Al[18F]-NOTA ([18F]2)
[18F]2 was obtained in 54–56% RCY (d.c.) and high SAs (21.4–26.7 GBq/μmol) after a total synthesis time of 108 min. Purification of the crude reaction mixture using a C18-cartridge gave [18F]2 in purities >96%.
Figure 1
Figure 1
Biodistribution of the radioligand [18F]2 in healthy athymic nude mice. The 18F-labeled tracer (1.33 nmol, 1.8–2.0 MBq) was injected via the tail vein before the mice were euthanized, and the organs collected at the appropriate time points.
Figure 2
Figure 2
Results of the biodistribution pretargeting CA19.9 with [18F]2/5B1-TCO. Subcutaneous BxPC3 xenograft bearing mice were administered 5B1-TCO (1.33 nmol) 72 h prior to the injection of the 18F-labeled tracer (1.33 nmol, 1.8–2.0 MBq) via the tail vein before the mice were euthanized, and the organs collected at the appropriate time points.
Figure 3
Figure 3
PET images of Tz-PEG11-Al[18F]-NOTA/5B1-TCO pretargeting strategy. Subcutaneous BxPC3 xenograft bearing mice were administered 5B1-TCO (1.33 nmol) 72 h prior to the injection of the 18F-labeled tracer (1.33 nmol, 18–20 MBq) via the tail vein. Transverse (top) and coronal (middle) planar images intersect the center of the tumors. The maximum intensity projections (MIPs, bottom) clearly illustrate tumor uptake after 1 h with increasing tumor-to-background ratios over the course of the experiment.

References

    1. Rossin R.; Robillard M. S. (2014) Pretargeted imaging using bioorthogonal chemistry in mice. Curr. Opin. Chem. Biol. 21, 161–9. 10.1016/j.cbpa.2014.07.023. - DOI - PubMed
    1. Goldenberg D. M.; Sharkey R. M.; Paganelli G.; Barbet J.; Chatal J. F. (2006) Antibody pretargeting advances cancer radioimmmunodetection and radioimmunotherapy. J. Clin. Oncol. 24, 823–34. 10.1200/JCO.2005.03.8471. - DOI - PubMed
    1. Zeglis B. M.; Sevak K. K.; Reiner T.; Mohindra P.; Carlin S. D.; Zanzonico P.; Weissleder R.; Lewis J. S. (2013) A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry. J. Nucl. Med. 54, 1389–96. 10.2967/jnumed.112.115840. - DOI - PMC - PubMed
    1. Zhu J.; Li S.; Waengler C.; Waengler B.; Lennox R. B.; Schirmmacher R. (2015) Synthesis of 3-chloro-6-((4-(di-tert-butyl[18F]-fluorosilyl)-benzyl)oxy)-1,2,4,5-tetrazine ([18F]SiFA-OTz) for rapid tetrazine-based 18F-radiolabeling. Chem. Commun. 51, 12415–18. 10.1039/C5CC03623B. - DOI - PubMed
    1. Goldenberg D. M.; Chang C.; Rossi E. A.; McBride W. J.; Sharkey R. M. (2012) Pretargeted Molecular Imaging and Radioimmunotherapy. Theranostics 2, 523–40. 10.7150/thno.3582. - DOI - PMC - PubMed

Publication types

MeSH terms